Association between the XRCC3 Thr241Met polymorphism and cervical cancer risk: a meta-analysis.

BACKGROUND Numerous epidemiological studies have been conducted to evaluate the association between variants of the DNA repair gene XRCC3 and cancer risk. Here we focused on one XRCC3 polymorphism and development of cervical cancer, performing a meta-analysis. METHODS The pooled association between the XRCC3 Thr241Met polymorphism and cervical cancer risk was assessed by odds ratios (ORs) and their 95% confidence intervals (95%CIs). RESULTS A total of 5 case-control studies met the inclusion criteria. The pooled ORs for the total included studies showed no association among homozygotes TT vs. CC: OR=1.93, 95%CI=0.68- 5.49, P=0.22; dominant model TT<TC vs. CC: OR=1.37, 95%CI=0.90-2.06, P=0.14; and recessive model TT vs. TC<CC: OR=1.76, 95%CI=0.68-4.55, P=0.25, but might be a slight risk factor for cervical cancer in heterozygote contrast TT vs. CT: OR= 1.33, 95%CI=1.04-1.71, P=0.02. In subgroup analysis, significant associations were found for Asians under all genetic models. CONCLUSIONS Our meta-analysis suggested the XRCC3 Thr241Met polymorphism might not act as a cervical cancer risk factor overall. However, in subgroup analysis, a significant association was found in Asians under all genetic models. The association should be studied with a larger, stratified population, especially for Asians.

[1]  X. Tian,et al.  Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population , 2013, Tumor Biology.

[2]  E. Khussainova,et al.  The Determination of Genetic Markers of Age-Related Cancer Pathologies in Populations from Kazakhstan , 2013, Front. Genet..

[3]  C. Golijow,et al.  XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) Single Nucleotide Polymorphisms in Cervical Cancer Risk , 2013, Pathology & Oncology Research.

[4]  Wencheng Zhang,et al.  Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk , 2013, Tumor Biology.

[5]  M. Ustav,et al.  Papillomavirus DNA replication - from initiation to genomic instability. , 2009, Virology.

[6]  Xiaohong He,et al.  Susceptibility of XRCC3, XPD, and XPG Genetic Variants to Cervical Carcinoma , 2008, Pathobiology.

[7]  Ji-Yeob Choi,et al.  Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies , 2007, Breast Cancer Research and Treatment.

[8]  N. Malats,et al.  Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[9]  D. Labuda,et al.  Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes , 2003, Journal of Human Genetics.

[10]  Christopher I Amos,et al.  Genetic susceptibility to lung cancer: the role of DNA damage and repair. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  Ammarin Thakkinstian,et al.  Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. , 2003, Journal of clinical epidemiology.

[12]  A. Giuliano,et al.  Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. , 2002, The Journal of infectious diseases.

[13]  A. Piazza,et al.  DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case‐control study , 2001, International journal of cancer.

[14]  J P Vandenbroucke,et al.  Bias in meta-analysis detected by a simple, graphical test , 1998 .

[15]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[16]  R. Tebbs,et al.  Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[18]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[19]  Xu Chen,et al.  Association of XRCC3 Thr241Met polymorphisms and gliomas risk: evidence from a meta-analysis. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[20]  T. Ishida,et al.  Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[21]  S. Chanock,et al.  Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. , 2009, The Journal of infectious diseases.

[22]  L. Rubenstein,et al.  Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. , 1998, BMJ.